Business · 17/08/2018
FDA and NIH Host Public Workshop on Regulation of Live Microbiome-Based Products for Disease Prevention, Treatment, and Cure
The FDA and NIH are hosting a public workshop to discuss the regulation of live microbiome-based products used to prevent, treat, or cure diseases in humans, bringing together government agencies, academia, and industry stakeholders.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →